Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : January Effect 2008 -- Ignore unavailable to you. Want to Upgrade?

To: RockyBalboa who wrote (15)	12/20/2007 8:31:14 AM
From: RockyBalboa	Read Replies (1) \| Respond to of 65

Microcap OCCX made a small deal: OccuLogix Sells SOLX Subsidiary Thursday December 20, 8:00 am ET TORONTO, ONTARIO--(MARKET WIRE)--Dec 20, 2007 -- OccuLogix, Inc. (NasdaqGM:OCCX - News)(Toronto:OC.TO - News) today announced that it has sold its SOLX, Inc. subsidiary to a company owned by that subsidiary's President and Founder, Doug Adams. ADVERTISEMENT Under the terms of the purchase agreement, the acquiror assumed all costs and liabilities of SOLX as of December 1, 2007, in addition to a $5 million payment obligation owed by OccuLogix to the former shareholders of SOLX, due on September 1, 2008. In addition, the purchase agreement provides that OccuLogix will receive a royalty of 3% of revenues generated by world-wide sales of the SOLX 790 Laser and the SOLX Gold Shunt, until such time as SOLX becomes cash-flow positive from its operations, and a royalty of 5% thereafter. Both the SOLX 790 Laser and the SOLX Gold Shunt have CE approval in Europe and are currently the subject of two randomized, multi-center studies in the United States. As first announced on October 9, 2007, OccuLogix continues to explore the full range of strategic alternatives available to it to maximize shareholder value. These alternatives may include, but are not limited to, the raising of capital through the sale of securities, one or more strategic alliances and the combination, sale or merger of all or part of the Company. OccuLogix stated that there can be no assurance that the exploration of strategic alternatives will result in a transaction. The Company does not intend to disclose developments with respect to the exploration of strategic alternatives unless and until its Board of Directors has approved a specific transaction. About OccuLogix, Inc.

To: RockyBalboa who wrote (15)	12/31/2007 3:10:51 PM
From: RockyBalboa	Read Replies (3) \| Respond to of 65

This day concludes my January buy activities: Due to the low prices I purchased a lot of junk too, so here we go: The more solid Picks: CC (4.35) IMB (6.00) NINE (3.20) PALM (5.75) SGTL (2.05) TLCV (3.00) WZEN (3.80) Cheap and doubtful stocks: NTMD 1.03 PAGI 2.85 CNLG 1.26 TSCC 3.00 SPDED 1.70 SYNX 1.30 WHI 1.36 Ultra Junk: AMCE 0.92 DFC 0.038 DIO 0.27 FCSE 0.52 IBIS 0.42 IMH 0.40 INHX 0.79 MATH 0.70 MFCO 0.70 NASI 0.25 NGEN 0.39 NTN 0.52 OCCX 0.10 OPBL 0.07 THLD 0.60 TRMM 0.48 WJCI 0.61 ZNCM 0.66 I hardly looked at homebuyers and did not want too many financial stocks in the portfolio, except those ones which look promising or where I had a short interest. Thats why I bought IMB or W but nothing common or preferred in names like NFI WM. Actually stock like IMH also hedges earlier exposure.